Atherosclerosis in APOE(*)3-Leiden transgenic mice from proliferative to atheromatous stage

Circulation

Volumn 99, Issue 2, 1999, Pages 276-283

  Lutgens, Esther ^a   Daemen, Mat ^a   Kockx, Mark ^d   Doevendans, Pieter ^a   Hofker, Marten ^b   Havekes, Louis ^c   Wellens, Hein ^a   De Muinck, Ebo D ^a,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

^d MIDDELHEIM HOSPITAL   (Belgium)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Atherosclerosis; Genetics

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E3 (LEIDEIN); DNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FAT INTAKE; FEMALE; FOAM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; ANIMAL; ARTERIOSCLEROSIS; ATHEROGENIC DIET; BIOSYNTHESIS; DISEASE MODEL; GENETICS; PATHOLOGY; PHENOTYPE;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; APOPTOSIS; ARTERIOSCLEROSIS; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA; FEMALE; FOAM CELLS; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE;

EID: 0032589979     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.2.276     Document Type: Article

References (33)

1. de Knijff P, van den Maagdenberg AM, Stalenhoef AF, Leuven JA, Demacker PN, Kuyt LP, Frants RR, Havekes LM. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J Clin Invest. 1991;88:643-655.
2. van den Maagdenberg AMJM, de Knijff P, Stalenhoef AFH, Leuven JA, Havekes LM, Frants RR. Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4. Biochem Biophys Res Commun. 1989;165:851-857.
3. van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 1994;93:1403-1410.
4. van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn I, van Vlijmen B, van der Boom H, Havekes LM, Frants RR. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem. 1993;268:10540-10545.
5. Groot PH, van Vlijmen BJ, Benson GM, Hofker MH, Schiffelers R, Vidgeon Hart M, Havekes LM. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure. Arterioscler Thromb Vasc Biol. 1996;16:926-933.
6. Leppänen P, Luoma JS, Hofker MH, Havekes LM, Ylä-Herttuala S. Characterization of atherosclerotic lesions in apo E3-Leiden transgenic mice. Atherosclerosis. 1998;136:147-152.
7. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res. 1990;31:859-869.
8. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
9. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mono-nuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985;54:589-599.
10. Kockx MM, Muhring J, Bortier H, De-Meyer GR, Jacob W. Biotin-or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 1996;148:1771-1777.
11. van Krimpen C, Smits JF, Cleutjens JP, Debets JJ, Schoemaker RG, Struyker-Boudier HA, Bosman FT, Daemen MJ. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol. 1991;23:1245-1253.
12. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol. 1995;147:229-234.
13. Virchow R. Die Cellularpathologie: Sechszehnte Vorlesung, 14 April 1858. Hildesheim; Germany: George Olms; 1966:317-329.
14. Orekhov AN, Andreeva ER, Mikhailova IA, Gordon D. Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions. Arteriosclerosis. 1998;139:41-48.
15. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 1995;147:668-677.
16. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res. 1993;73:223-231.
17. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A. 1990;87:4600-4604.
18. Brandi R, Richter T, Haug K, Wilhelm MG, Maurer PC, Nathrath W. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation. 1997;96:3360-3368.
19. Pickering JG, Weir L, Jekanowski J, Kearney MA, Isner JM. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 1993;91: 1469-1480.
20. Katsuda S, Coltrera MD, Ross R, Gown AM. Human atherosclerosis. IV: immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol. 1993;142:1787-1793.
21. Orekhov AN, Kosykh VA, Repin VS, Smimov VN. Cell proliferation in normal and atherosclerotic aorta, II: autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest. 1983;48:749-754.
22. Stary HC, McMillan GC. Kinetics of cellular proliferation in experimental atherosclerosis: radioautography with grain counts in cholesterol-fed rabbits. Arch Pathol. 1970;89:173-183.
23. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1990;10:680-687.
24. Kockx MM, de Meyer GR, Muhring J. Bult H, Bultinck J, Herman AG. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis. 1996;120:115-124.
25. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 1995;147:251-266.
26. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
27. Han DKM, Haudenschild CCH, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
28. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
29. Kockx MM, de Meyer GRY, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;98:2307-2315.
30. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57: 791-804.
31. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis H, DeBoer LWV, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic R, Hirsch LJ. Coronary angiographic changes with lovastatin therapy. Ann Intern Med. 1993;119:969-976.
32. Martinez-Gonzalez J, Badimon L. Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: implication for in vivo interventions in the porcine model. Eur J Clin Invest. 1996;26:1023-1032.
33. Spagnoli LG, Orlandi A, Santeusanio G. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis. 1991;88:87-92.